Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioNTech SE ADR buy MoneyMoney

BioNTech SE ADR
Start price
€67.74
13.07.20 / 0%
Target price
€250.00
04.11.21
Performance (%)
254.74%
End price
€240.30
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €240.30. The BUY prediction by MoneyMoney for BioNTech SE ADR saw massive gains of 254.74%. MoneyMoney has a follow-up prediction for BioNTech SE ADR where he still thinks BioNTech SE ADR is a Buy.
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

According to MoneyMoney what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Differentiated customer and product portfolio
Valuable balance sheet
High Investments for future growth
Future proof or reliable business model
Capable Management
Innovative
Growths faster than the competition
Stable Large shareholder and/or long term investor
Revenue growth > 30% per year expected
Well known brand
Top 10 in its market
Could be worthwhile Investment >10% per year
Good culture
Strong uniques
positive Cash Flow expected
Sustainability is important
Good rating
Cons
Higher risks for its business
Significant cyclical dependencies
Low dividend yield expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital

Comments by MoneyMoney for this prediction

In the thread Biontech SE diskutieren
Prediction Buy
Perf. (%) 254.74%
Target price 75.000
Change
Ends at 04.11.21

Buy mit Kursziel 75,0

MoneyMoney 
0
Report Share
13.07.20
Prediction Buy
Perf. (%) 254.74%
Target price 80.000
Change
Ends at 04.11.21

Kursziel geändert auf 80,0

MoneyMoney 
0
Report Share
26.07.20
Prediction Buy
Perf. (%) 254.74%
Target price 75.000
Change
Ends at 04.11.21

Kursziel geändert auf 75,0

MoneyMoney 
0
Report Share
09.08.20
Prediction Buy
Perf. (%) 254.74%
Target price 60.000
Change
Ends at 04.11.21

Kursziel geändert auf 60,0

MoneyMoney 
0
Report Share
07.09.20
Prediction Buy
Perf. (%) 254.74%
Target price 70.000
Change
Ends at 04.11.21

Kursziel geändert auf 70,0

MoneyMoney 
0
Report Share
08.09.20
Prediction Buy
Perf. (%) 254.74%
Target price 95.000
Change
Ends at 04.11.21

Kursziel geändert auf 95,0

MoneyMoney 
0
Report Share
18.10.20
Prediction Buy
Perf. (%) 254.74%
Target price 90.000
Change
Ends at 04.11.21

Kursziel geändert auf 90,0

MoneyMoney 
0
Report Share
02.11.20
Prediction Buy
Perf. (%) 254.74%
Target price 105.000
Change
Ends at 04.11.21

Kursziel geändert auf 105,0

MoneyMoney 
0
Report Share
16.11.20
Prediction Buy
Perf. (%) 254.74%
Target price 100.000
Change
Ends at 04.11.21

Kursziel geändert auf 100,0

MoneyMoney 
0
Report Share
28.11.20
Prediction Buy
Perf. (%) 254.74%
Target price 120.000
Change
Ends at 04.11.21

Kursziel geändert auf 120,0

MoneyMoney 
0
Report Share
14.12.20
Prediction Buy
Perf. (%) 254.74%
Target price 110.000
Change
Ends at 04.11.21

Kursziel geändert auf 110,0

MoneyMoney 
0
Report Share
09.01.21
Prediction Buy
Perf. (%) 254.74%
Target price 115.000
Change
Ends at 04.11.21

Kursziel geändert auf 115,0

MoneyMoney 
0
Report Share
07.02.21
Prediction Buy
Perf. (%) 254.74%
Target price 110.000
Change
Ends at 04.11.21

Kursziel geändert auf 110,0

MoneyMoney 
0
Report Share
20.02.21
Prediction Buy
Perf. (%) 254.74%
Target price 100.000
Change
Ends at 04.11.21

Kursziel geändert auf 100,0

MoneyMoney 
0
Report Share
08.03.21
Prediction Buy
Perf. (%) 254.74%
Target price 110.000
Change
Ends at 04.11.21

Kursziel geändert auf 110,0

MoneyMoney 
0
Report Share
22.03.21
Prediction Buy
Perf. (%) 254.74%
Target price 120.000
Change
Ends at 04.11.21

Kursziel geändert auf 120,0

MoneyMoney 
0
Report Share
04.04.21
Prediction Buy
Perf. (%) 254.74%
Target price 150.000
Change
Ends at 04.11.21

Kursziel geändert auf 150,0

MoneyMoney 
0
Report Share
17.04.21
Prediction Buy
Perf. (%) 254.74%
Target price 175.000
Change
Ends at 04.11.21

Kursziel geändert auf 175,0

MoneyMoney 
0
Report Share
01.05.21
Prediction Buy
Perf. (%) 254.74%
Target price 190.000
Change
Ends at 04.11.21

Kursziel geändert auf 190,0

MoneyMoney 
0
Report Share
15.05.21
Prediction Buy
Perf. (%) 254.74%
Target price 200.000
Change
Ends at 04.11.21

Kursziel geändert auf 200,0

MoneyMoney 
0
Report Share
29.05.21
Prediction Buy
Perf. (%) 254.74%
Target price 210.000
Change
Ends at 04.11.21

Kursziel geändert auf 210,0

MoneyMoney 
0
Report Share
14.06.21
Prediction Buy
Perf. (%) 254.74%
Target price 200.000
Change
Ends at 04.11.21

Kursziel geändert auf 200,0

MoneyMoney 
0
Report Share
10.07.21
Prediction Buy
Perf. (%) 254.74%
Target price 270.000
Change
Ends at 04.11.21

Kursziel geändert auf 270,0

MoneyMoney 
0
Report Share
27.07.21
Prediction Buy
Perf. (%) 254.74%
Target price 320.000
Change
Ends at 04.11.21

Kursziel geändert auf 320,0

MoneyMoney 
0
Report Share
30.08.21
Prediction Buy
Perf. (%) 254.74%
Target price 250.000
Change
Ends at 04.11.21

Kursziel geändert auf 250,0

MoneyMoney 
0
Report Share
03.10.21

Current prediction by MoneyMoney for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€81.35
18.04.24
€100.00
18.04.25
1.66%
08:12

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
18.04.24 0%

Stopped prediction by MoneyMoney for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€160.55
11.12.22
€120.00
11.12.23
-42.05%
12.12.23

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
11.12.22 0%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€210.00
14.11.21
€185.00
14.11.22
-25.98%
15.11.22

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
MoneyMoney 
14.11.21 0%